HealthTree Logo
search more_vert
App Logo
person Sign In / Create Account

Clinical Expertise

Dr. Altman's research is focused on increasing understanding of the role of aberrant signal transduction pathways in the development of myeloid neoplasms; defining molecular targets for the treatment of leukemias; and generating clinical trials based on such research work. With extensive experience in translational work in this area, she actively participated in work to define the roles mTOR and Mnk pathways in the generation of anti-leukemic responses in acute myeloid leukemia (AML) and chronic myeloid leukemia (CML).


Robert H. Lurie Comprehensive Cancer Center of Northwestern University: 675 N St Clair St 21st Floor, Chicago, IL 60611, USA

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Astellas Pharma

Follow Us

facebook instagram twitter youtube